Public Company News

Innovent Announces the Results of the Phase Ib Clinical Trial of IBI302, a First-in-class Anti-VEGF and Anti-Complement Bi-specific Fusion Protein for Neovascular Age-Related Macular Degeneration at 2021 American Academy of Ophthalmology

SAN FRANCISCO and SUZHOU, China, Nov. 15, 2021 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2021-11-15 08:00 3874

Axcelis Announces Participation In SEMICON Japan 2021

Showcase Features the Purion and GSD Ovation Series of Ion Implanters Designed to Meet the Emerging Needs of Power Device, Image Sensor and Memory Markets BEVERLY, Mass., Nov. 15, 2021 /PRNewswire/ -- Axcelis Technologies, Inc. (Nasdaq: ACLS), a leading supplier of enabling ion implantation solut...

2021-11-15 07:00 3405

SMX and LVMH Métiers d'Art collaboratively enable complete traceability of origin for its raw materials.

MELBOURNE, Australia, Nov. 15, 2021 /PRNewswire/ -- Security Matters ( https://smx.tech/home ) (ASX: SMX) ("SMX" and "the Company") a next-generation brand protection and authentication service provider announces a new collaboration with LVMH Métiers d'Art on a series of ...

2021-11-15 04:00 4004
1 ... 901902903904905